Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
187,265,283
-
Share change
-
+1,272,248
-
Total reported value
-
$58,619,371,628
-
Put/Call ratio
-
115%
-
Price per share
-
$313.12
-
Number of holders
-
1,004
-
Value change
-
+$470,268,951
-
Number of buys
-
460
-
Number of sells
-
416
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q3 2017
As of 30 Sep 2017,
BIOGEN INC. - COM (BIIB) was held by
1,004 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
187,265,283 shares.
The largest 10 holders included
BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Clearbridge Investments, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., and NORTHERN TRUST CORP.
This page lists
1,009
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.